secwatch / observer
8-K filed October 2, 2025, 7:59 PM ET ticker DD CIK 0001666700
debt confidence high sentiment neutral materiality 0.55

DuPont de Nemours, Inc. (DD): debt financing — DuPont completes $2.105B debt exchange; new notes tied to Electronics separation

DuPont de Nemours, Inc.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.95

DuPont de Nemours, Inc. incurred senior notes of $1,584,398,000 aggregate principal amount of 4.725% Notes due 2028; $225,963,000 aggregate principal amount of 5.319% No with U.S. Bank Trust Company, National Association at 4.725%, 5.319%, 5.419% maturing November 15, 2028; November 15, 2038; November 15, 2048.

Instrument
senior notes
Principal
$1,584,398,000 aggregate principal amount of 4.725% Notes due 2028; $225,963,000 aggregate principal amount of 5.319% No
Counterparty
U.S. Bank Trust Company, National Association
Rate
4.725%, 5.319%, 5.419%
Maturity
November 15, 2028; November 15, 2038; November 15, 2048
Event
incurrence
Exact text from the filing
On October 2, 2025, DuPont issued $1,584,398,000 aggregate principal amount of 4.725% Notes due 2028 (the "New 2028 Notes") in exchange for the 2028 Notes tendered and accepted by DuPont, $225,963,000 aggregate principal amount of 5.319% Notes due 2038 (the "New 2038 Notes") in exchange for the 2038 Notes tendered and accepted by DuPont and $294,781,000 aggregate principal amount of 5.419% Notes due 2048 (the "New 2048 Notes" and, collectively with the New 2028 Notes and the New 2038 Notes, the "New Notes") in exchange for the 2048 Notes tendered and accepted by DuPont.
View on SEC.gov

304 debt financings filed in the last 30 days. Browse all debt financings →

DuPont de Nemours, Inc. filing history →

Source: SEC EDGAR
accession 0001193125-25-228420
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.